Prazosin for Alcohol Use Disorder
Prazosin is a blood-pressure medication studied off-label for alcohol use disorder because it calms the overactive stress system tied to craving and withdrawal. The evidence is mixed: the largest trial found no overall benefit, but people with severe withdrawal symptoms or co-occurring PTSD may respond strongly. It is not first-line, and the choice belongs with a clinician.
Battling addiction & ready for help?
What Is Prazosin and Why Use It for Drinking?
Prazosin is a blood-pressure pill that researchers have spent the last fifteen years testing for a very different job, quieting the urge to drink. If your doctor has raised it, or you have read that it might help with cravings, you are looking at a real and active area of research, not a fringe idea. What you are also looking at is a mixed picture, where the drug seems to help some people a lot and others not at all.
The medical name for what prazosin does is alpha-1 adrenergic antagonist. In plain terms, it blocks one of the switches that the body’s stress chemical, norepinephrine, uses to flip the body into a keyed-up, fight-or-flight state. Heavy drinking over years pushes that stress system into overdrive, and that overdrive is tied to craving and to the rough stretch of withdrawal. The idea behind prazosin is to turn the volume back down.
Two things are true at once and neither cancels the other. Prazosin is not approved by the FDA for alcohol use disorder. It is approved for high blood pressure, and it is widely used off-label for the nightmares that come with post-traumatic stress disorder. Yet for a specific group of people, especially those with severe withdrawal symptoms or co-occurring trauma, the evidence is more encouraging than a quick glance suggests. What follows is where it helps, where it does not, and how the safety works.
Feeling faint, dizzy, or unsure whether to keep drinking on this medication is common and treatable. Call or text 988 any time; do not stop heavy daily drinking on your own.
What to do:
- If you feel faint or your heart is racing, sit or lie down and let it pass, then tell your prescriber what happened before your next dose.
- If you are thinking about suicide or you are in danger right now, call or text 988 (Suicide and Crisis Lifeline), any time.
- Do not try to quit heavy daily drinking on your own. Sudden alcohol withdrawal can cause seizures and delirium, and a supervised medical detox handles it safely. Find alcohol detox and treatment →
- It is off-label, not first-line: naltrexone, acamprosate, and disulfiram remain the only medications the FDA has approved for alcohol use disorder, and prazosin is used off-label.
- The biggest trial found no overall benefit: a rigorous trial in veterans with PTSD and alcohol dependence found no medication effect on drinking, sleep, or PTSD symptoms[1].
- One subgroup responded strongly: in people with high alcohol-withdrawal severity, prazosin cut heavy-drinking days to 7.07% versus 35.58% on placebo by week 12[2].
- Real-world doses run low: among veterans prescribed prazosin for PTSD-related sleep problems, the average dose was only 2.6 mg a day and just 7% reached the therapeutic target[3].
How Prazosin Works Against Cravings
Understanding the mechanism is not biology for its own sake. It explains why prazosin seems to help some people and not others, and why the research keeps circling back to one particular group.
The Stress System Behind Heavy Drinking
Deep in the brainstem sits a small cluster of cells called the locus coeruleus, which floods the brain with norepinephrine and sets off the fight-or-flight response. In someone who has been drinking heavily for a long time, this alarm system stops resetting properly. It fires too easily, too hard, and for too long. Stress, or even a cue tied to past drinking, can then set off an urge that feels impossible to ride out. Researchers call this stress-driven relapse, and it has been mapped in careful animal work.
Prazosin steps into that circuit. By blocking the alpha-1 receptor, it blunts what norepinephrine can do downstream, which lowers blood pressure, softens the stress-driven jump in heart rate, and, in theory, quiets stress-triggered craving. Animal studies give the mechanism real weight. In rats, prazosin blocked relapse to alcohol seeking that had been kicked off by a chemical stressor, with the effect traced to stress- and reward-related regions including the prefrontal cortex and the amygdala[4]. It also blocked relapse triggered through a separate, opioid-linked stress pathway, a hint that its reach goes beyond a single chemical route[5].
Animal evidence does not prove a drug works in people. What it does is give a coherent reason to expect a benefit, and it points at exactly who should benefit most, the people whose stress system is running hottest.
From the Lab to the Person
The human version of that same logic is straightforward. Blocking alpha-1 receptors dampens the body’s response to its own stress chemical, and in people early in recovery, prazosin has measurably done that. In a study of inpatients in early abstinence, prazosin reduced stress-triggered alcohol craving and anxiety while lowering the stress hormones cortisol and ACTH, direct evidence of the stress-axis calming that the theory predicts[6].
That is the throughline of the whole prazosin story. It is not a reward blocker like naltrexone and it is not an aversive deterrent like disulfiram. It works upstream, on the stress and arousal that drive some people back to drinking, which is why the people it helps tend to share a particular profile.
Where Prazosin and PTSD Overlap
People with PTSD are far more likely to develop a drinking problem, and many people struggling with alcohol carry unaddressed trauma. The two conditions share the same engine, an overactive noradrenergic stress response, whether it was set off by trauma or by years of drinking and withdrawal. That shared biology is a big part of why prazosin ended up being tested for drinking at all.
Prazosin earned its off-label reputation treating the sleep side of PTSD first. A recent review that pooled ten trials covering 648 patients found that prazosin meaningfully improved insomnia and nightmares, even though it did not significantly improve overall PTSD symptom severity[7]. That established track record for trauma-related nightmares is what made researchers ask a natural follow-up question. If the same drug calms the trauma-driven stress response, could it also ease drinking in people carrying both conditions?
For someone whose drinking is tangled up with nightmares, hyperarousal, and broken sleep, prazosin holds out the possibility of easing the trauma symptoms and the drinking at the same time. That possibility is real, but it comes with the same caution that runs through this whole topic. The evidence is uneven, and it matters a great deal which person is taking it.
What the Studies Actually Show
The research on prazosin for drinking does not line up neatly. Some trials found a genuine benefit. The largest and most rigorous one did not. Making sense of why they disagree matters more than any single headline result, because the disagreement itself points to who the drug is for.
The Early Positive Signals
The first evidence came from small pilot trials, and they leaned encouraging. An early pilot in 24 people found that prazosin reduced drinking days and drinks per week among the men who finished the trial[8]. A later pilot in 30 people who had both PTSD and alcohol dependence found bigger drops in drinking days and heavy-drinking days on prazosin than on placebo, though drowsiness showed up on more days in the prazosin group[9].
The most important early positive result came from a larger trial of 92 people who had alcohol use disorder but not PTSD, a deliberate design meant to test whether the benefit depended on trauma at all[10]. Over time, the prazosin group showed greater reductions in both drinks per week and heavy-drinking days than the placebo group[10]. That hinted the stress mechanism might matter for a broader slice of people, not only those with PTSD.
The Largest Trial Found No Benefit
Then came the most rigorous test to date, a 13-week trial in veterans with both PTSD and alcohol dependence. It found no significant effect on drinking, on sleep, or on PTSD symptoms[1]. This result is real and it should not be brushed aside. The authors concluded that prazosin did not help an actively drinking group and that the presence of a comorbid condition appeared to affect how well the medication worked[1].
A null result in the very population the theory pointed to is sobering. But a single average can bury a real effect if the drug only works in part of the group, and that is exactly the thread the next studies pulled.
Why One Subgroup Responds and Others Do Not
The clearest signal in this entire body of research comes from a trial that split people up front by how severe their alcohol-withdrawal symptoms were. The gap between groups was striking.
| Baseline Withdrawal Severity | Heavy-Drinking Days at Week 12, Prazosin | Heavy-Drinking Days at Week 12, Placebo |
|---|---|---|
| High baseline withdrawal symptoms | 7.07%[2] | 35.58%[2] |
| Low baseline withdrawal symptoms | No benefit over placebo[2] | No benefit over placebo[2] |
Among people with high withdrawal severity, prazosin brought heavy-drinking days down to 7.07% by week 12, against 35.58% on placebo, a difference that held up statistically[2]. Among people with low withdrawal severity, prazosin did nothing measurable[2]. This was not a lucky slice found after the fact. It was planned in advance and grounded in the biology, since alcohol withdrawal is itself a state of noradrenergic overdrive, and alpha-1 blockade is aimed right at it.
In the group with high withdrawal severity, prazosin cut heavy-drinking days to roughly a fifth of the placebo rate, 7.07% versus 35.58%, a notably large effect within that trial[2].
Other trials point the same direction. Response seems to track with signs of an overactive stress system rather than with the diagnosis on the chart. In a trial of active-duty soldiers, prazosin did not beat placebo across the whole group, but in the subgroup with an elevated standing heart rate, a marker of high noradrenergic tone, it significantly reduced drinks per day, drinking days, and heavy-drinking days[11]. In that same trial, the subgroup with co-occurring PTSD showed significantly greater drops in craving on prazosin than on placebo[11]. A separate trial found no benefit across its full sample either, but did find a reduction in drinks per week among people who actually reached an adequate dose, with blood-pressure patterns helping predict who responded[12]. Brain-imaging work adds a final layer, linking a person’s stress-circuit response to how well they did on the drug[13].
Put together, a coherent picture emerges. Prazosin appears to work in people whose stress system is running hot, whether that shows up as severe withdrawal, an elevated heart rate, PTSD-driven hyperarousal, or a stress-reactive brain response. The big null trial may reflect a real subgroup effect watered down in a mixed crowd, not the absence of any effect at all. That idea is plausible and clinically useful, and it has not yet been confirmed in a trial built to test it directly.
Who Might Benefit From Prazosin
Nobody should reach for prazosin just because it exists. The evidence points to a specific profile, not a general recommendation, and the fair summary is that this is a targeted option for the right person.
Based on what the trials show, a clinician might reasonably weigh off-label prazosin for someone with alcohol use disorder who has:
- Craving that reliably spikes with stress or emotional distress more than with the sight of a drink or a social setting
- Co-occurring PTSD, especially with nightmares, hyperarousal, or insomnia, where one drug might help on two fronts[7]
- High alcohol-withdrawal symptom severity at baseline, measured with a tool like the CIWA-Ar, the strongest predictor of response in the research[2]
- Elevated standing heart rate or blood-pressure patterns that hint at an overactive stress response[11]
- An inadequate response to naltrexone or acamprosate after a fair trial
- No severe low blood pressure, no heavy use of other blood-pressure medications, and no condition that makes fainting on standing more likely
That is a precision-medicine frame, not a green light for broad prescribing. It describes a subgroup the evidence supports as a plausible target, one that a good clinician can help you figure out whether you fit.
Dosing and Safety Basics
Prazosin is generally started low and raised slowly, and the reason is baked into how the drug works.
How It Is Started and Dosed
Prazosin has a short half-life, so it clears the body fairly fast and is usually taken more than once a day to keep its effect steady. The trials that found a benefit used a consistent approach, starting small and building up over one to two weeks, with the largest dose given at bedtime. The positive trial in people without PTSD titrated up to 4 mg in the morning, 4 mg in the afternoon, and 8 mg at bedtime, a total of 16 mg a day[10]. Other trials that saw effects used the same 16 mg-a-day target[2][6].
Loading the biggest dose at night is deliberate. The main side effect of any alpha-1 blocker is a drop in blood pressure when standing up, sometimes with dizziness or a faint feeling, and it is most pronounced with the very first doses and each step up. Taking the largest dose while lying down at bedtime means the sharpest blood-pressure dip happens during sleep, which is why the drug is started low and titrated slowly. Rising slowly from sitting or lying down, especially in the first weeks, is a standard precaution.
| Setting | Typical Pattern | What Happened |
|---|---|---|
| Positive AUD trial, no PTSD | Titrated to 4 mg morning, 4 mg afternoon, 8 mg bedtime, 16 mg a day[10] | Greater drop in drinks per week and heavy-drinking days than placebo[10] |
| Real-world VA prescribing for PTSD sleep | Average 2.6 mg a day[3] | Only 7% reached the therapeutic target of at least 6 mg a day[3] |
In real-world VA prescribing of prazosin for PTSD-related sleep problems, the average dose was just 2.6 mg a day and only 7% of patients reached the therapeutic target of at least 6 mg a day, far below the doses used in trials that showed a drinking benefit[3].
That gap between research protocols and everyday practice matters. Across large cohorts of veterans prescribed prazosin for PTSD-related sleep disturbance, most never came close to the doses used in the trials that reported benefit, and only about 19% took it consistently enough to count as adequate adherence[3]. A drug that is never titrated to an effective dose cannot show what it can do.
Side Effects and Cautions
Across the drinking trials, the side effects that came up most were drowsiness and swelling. Drowsiness was significantly more common on prazosin in the pilot trials[9], and the larger trial reported both drowsiness and swelling[10]. One trial linked its disappointing overall result partly to poor tolerability and adherence, with a meaningful share of participants never reaching an adequate dose[12]. The trial reports do not include detailed tables of dropouts by side effect, which limits how precisely a clinician can tell you what to expect.
The clearest caution is about blood pressure. Prazosin should be used carefully in anyone already on blood-pressure medication, since the effects can add up, and in people with heart conditions or trouble regulating blood pressure. Alcohol affects blood pressure and the nervous system too, so drinking on top of a dose can make dizziness and the risk of fainting more noticeable, which is one more reason your prescriber needs to know how much you drink.
Where Prazosin Fits Among Alcohol Medications
Three medications are FDA-approved specifically for alcohol use disorder, and for most people they are the place to start before anything off-label is considered.
| Medication | How It Works | Status for Alcohol Use Disorder |
|---|---|---|
| Naltrexone | Blocks opioid receptors, reducing alcohol’s rewarding kick | FDA-approved, first-line |
| Acamprosate | Helps steady glutamate signaling that heavy drinking throws off | FDA-approved, first-line |
| Disulfiram | Causes an unpleasant reaction if a person drinks | FDA-approved, first-line |
| Prazosin | Blocks alpha-1 stress receptors, aimed at stress-driven craving | Off-label, selective use |
The full menu of approved options, and how to think about starting one, lives on the alcohol medications page. Gabapentin and topiramate also carry reasonable off-label evidence for cutting heavy drinking, and baclofen has been studied widely in Europe with mixed results. Prazosin is not meant to replace any of these. It is a targeted choice for people whose drinking is driven mainly by stress or trauma-linked hyperarousal, or who have not responded to a first-line medication.
Combining Prazosin With Other Medications
Early work on pairing prazosin with another drug is promising but small. The most interesting signal so far comes from combining it with naltrexone. In a proof-of-concept trial in veterans, adding prazosin to naltrexone produced larger reductions in craving, drinking days, and heavy-drinking days than naltrexone alone, with effect sizes above 0.8[14]. That is a strong signal from a small study, and it needs a larger trial to confirm. A French trial pairing prazosin with cyproheptadine reduced total alcohol consumption by 23.6 grams a day in its higher-dose group[15]. Animal studies support the prazosin-and-naltrexone pairing as well[16][17].
A Longer-Acting Cousin, Doxazosin
Doxazosin is a close relative of prazosin that stays in the body longer, which in principle allows once-daily dosing. In the same rat study that looked at prazosin, doxazosin produced a slightly larger reduction in alcohol seeking, a 78% drop versus prazosin’s 69%[4]. That is animal data, not a human result, and no head-to-head trial in people with alcohol use disorder has been done. Still, its once-a-day potential is worth watching, precisely because the real-world dosing failures with prazosin suggest that a simpler schedule could help people actually reach an effective dose.
What the Research Still Has to Prove
For all the encouraging subgroup signals, this field has real gaps, and naming them is part of a fair picture.
The trials have leaned heavily on veterans and active-duty service members. The largest trial enrolled veterans[1], and a major trial recruited active-duty soldiers[11], both groups that skew male. That leaves women, civilians, and racially diverse populations underrepresented, so it is genuinely unclear how well these findings carry over to people outside that slice. The real-world prescribing data show the same gap from a different angle. Among veterans treated with prazosin for PTSD-related sleep problems, women reached therapeutic doses less often than men, and minority veterans were less likely to stay adherent, meaning the people the research is meant to help are often the least likely to get a fair trial of the medication in practice[3].
The other missing piece is a trial that picks people in advance by the markers that seem to predict response, high withdrawal severity, an elevated heart rate, or brain-imaging signs of stress reactivity, rather than sorting them out after the fact. That kind of enriched trial has not been done. It is the study that would turn a promising subgroup signal into a confirmed treatment path, and until it exists, prazosin for drinking stays an evidence-guided option rather than a settled one.
None of that means you have to wait for perfect proof to get help now. Effective, approved treatments exist today, and a clinician who understands both your drinking pattern and your full medication list can help you work out where, if anywhere, prazosin fits.
Getting Help for Alcohol Use Disorder
If your drinking has its hooks in your stress, your sleep, or old trauma, hold onto this. Alcohol use disorder is a condition of the brain’s reward and stress systems, not a failure of character, and it responds to treatment. Prazosin may turn out to be part of the answer for a specific group of people, but it is one tool among several, and the proven, FDA-approved medications are the place most people should start.
The strongest move is to get real help for the drinking and let a clinician weigh the options with you. If you have been drinking heavily every day, that starts with a supervised detox rather than stopping cold on your own, since withdrawal can be dangerous without support, followed by the medication and counseling that make sobriety hold.
To see how this fits the bigger picture and the road out:
- The full set of approved choices, in alcohol medications
- How a medically supervised process handles tapering off alcohol safely
- Whether the pattern fits you, in am I an alcoholic
- How one proven medication supports staying off alcohol, with naltrexone for alcohol
Frequently asked questions
Is Prazosin FDA-Approved for Alcohol Use Disorder?
No. Prazosin is approved for high blood pressure and is used off-label for the nightmares of post-traumatic stress disorder. Naltrexone, acamprosate, and disulfiram remain the only medications the FDA has approved for alcohol use disorder, so any use of prazosin for drinking is off-label. "Off-label" means a clinician prescribes an approved drug for a different condition based on emerging evidence, which is common and legal, not experimental in a reckless sense. For most people, the approved options are the place to start before anything off-label is weighed.
Does Prazosin Actually Reduce Drinking?
It depends heavily on the person. The largest and most rigorous trial, in veterans with PTSD and alcohol dependence, found no effect on drinking, sleep, or PTSD symptoms[1]. But a trial that split people by withdrawal severity found that in those with high alcohol-withdrawal symptoms, prazosin cut heavy-drinking days to 7.07% versus 35.58% on placebo by week 12, while it did nothing for people with low withdrawal severity[2]. The benefit appears real for a specific subgroup rather than for everyone.
Who Is Most Likely to Benefit From Prazosin?
The research points to people whose stress system is running hot. That includes those with high alcohol-withdrawal symptom severity, the strongest predictor of response[2], and people with an elevated standing heart rate, who saw significant reductions in drinking in one trial even though the overall group did not[11]. People with co-occurring PTSD, hyperarousal, or nightmares may also be reasonable candidates. It is a targeted option for a specific profile, decided with a clinician, not a general recommendation.
Can You Drink Alcohol While Taking Prazosin?
It is something to discuss frankly with your prescriber rather than hide. Prazosin lowers blood pressure, and alcohol affects blood pressure and the nervous system too, so drinking on top of a dose can make dizziness and the risk of fainting more noticeable, especially with the first doses or a dose increase. If you feel faint or your heart is racing, sit or lie down. If you have been drinking heavily every day, do not stop abruptly on your own, since alcohol withdrawal can be dangerous, and a supervised medical detox is the safer path.
What Are the Side Effects of Prazosin?
In the alcohol trials, the side effects reported most often were drowsiness and swelling. Drowsiness was significantly more common on prazosin in a pilot trial[9], and a larger trial reported both drowsiness and swelling[10]. The main safety concern with any alpha-1 blocker is a drop in blood pressure on standing, which is why prazosin is started low, raised slowly, and dosed with the largest amount at bedtime. Caution is needed for anyone already taking blood-pressure medication, since the effects can add up.
How Does Prazosin Compare to Naltrexone for Alcohol?
They work in different ways and sit at different tiers. Naltrexone is FDA-approved and first-line, blocking opioid receptors to reduce alcohol's rewarding effect. Prazosin is off-label and targets the stress side of craving by blocking alpha-1 receptors. For most people, naltrexone or another approved medication is tried first. Early research on combining the two is promising, though, with a small proof-of-concept trial finding that adding prazosin to naltrexone produced larger reductions in craving and drinking than naltrexone alone, at effect sizes above 0.8[14].
Get Treatment Help
If you or someone you love is struggling with addiction, getting help is just a phone call away, or consider trying therapy online with BetterHelp.
Exclusive offer: 20% Off BetterHelp*Following links to the BetterHelp website may earn us a commission that helps us manage and maintain AddictionHelp.com. *Get 20% off your first month of BetterHelp. Offer valid for new BetterHelp users only. Offer cannot be combined with insurance.
- Fact-Checked
- Editor
